journal article·2021-09

A review on biomedical applications, prospects, and challenges of rare earth oxides

M. Khalid Hossain, M. Ishak Khan, A. El-Denglawey

Publisher page

Abstract

Abstract Rare earth oxides (REOs) have gathered interest in recent years due to their multifarious applications in the biomedical field. A focused review depicting their applicability along with their prospects and associated challenges in this specific field is absent in the literature. This review attempts to specifically report the applications of six (6) REOs in the biomedical field to properly represent the advancement and state-of-the-art of the sector. While the applications can be divided into antimicrobial, tissue engineering, drug delivery, bio-imaging, cancer treatment, cell tracking and labeling, biosensor, reduction of oxidative stress, theranostic, and miscellaneous applications, it is found that the bio-imaging aspect is the most widely applied and holds the most promising ground from a biomedical perspective. Specifically, REOs have shown successful implementation in real water and sewage samples as antimicrobial agents, in bone tissue regeneration as biologically active and healing material, in anti-cancer therapeutic maneuvers by providing substantial binding sites for multifarious functional groups, in dual-modal and multi-modal MRI imaging by providing excellent or increased contrasting capabilities, in biosensing aspects by providing fast and parameter-dependent sensing, and so on. As per their prospects, it is predicted that several REOs will rival and/or replace currently available commercial bio-imaging agents, due to superior doping flexibility, healing mechanism in biological systems, and economic features in terms of bio-imaging and sensing. Furthermore, this study extends the findings with regards to the prospects and desired cautions in their applications, suggesting that while they are promising in multiple aspects, their cytotoxicity in particular cell lines should not be overlooked. This study will essentially invoke multiple studies to investigate and improve the utilization of REOs in the biomedical field.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Electrochemical sensor and biosensor platforms based on advanced nanomaterials for biological and biomedical applications10.1016/j.bios.2017.12.031 ↗
2. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications10.1016/j.addr.2019.01.005 ↗
3. Advances in Magnetic Nanoparticles for Biomedical Applications10.1002/adhm.201700845 ↗
4. Recent progress of magnetic nanoparticles in biomedical applications: A review10.1002/nano.202000162 ↗
5. Localized Surface Plasmon Resonance in Semiconductor Nanocrystals10.1021/acs.chemrev.7b00613 ↗
6. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review10.1016/j.jare.2018.06.005 ↗
7. Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics10.1007/s13205-018-1286-z ↗
8. A graphene-based broadband optical modulator10.1038/nature10067 ↗
9. Nanoscale zero-valent iron: Future prospects for an emerging water treatment technology10.1016/j.jhazmat.2011.11.073 ↗
10. Recent progress in barium zirconate proton conductors for electrochemical hydrogen device applications: A review10.1016/j.ceramint.2021.05.167 ↗
11. A review on experimental and theoretical studies of perovskite barium zirconate proton conductors10.1007/s42247-021-00230-5 ↗
12. Oxide-Based Electrolyte-Gated Transistors for Spatiotemporal Information Processing10.1002/adma.202003018 ↗
13. Rare-Earth oxide nanopolyhedra, nanoplates, and nanodisks, Angew. Chemie Int
14. Fanciulli · 2007
15. Hydrogen isotope dissolution and release behavior of rare earth oxides10.1080/15361055.2020.1728173 ↗
16. Isotopic effect of proton conductivity in gadolinium sesquioxide10.1016/j.fusengdes.2021.112555 ↗
17. Conductivity of gadolinium (III) oxide (Gd2O3) in hydrogen-containing atmospheres
18. Biological applications of rare-earth based nanoparticles10.1021/nn202378b ↗
19. Synthesis and morphological control of rare earth oxide nanoparticles by solvothermal reaction10.1007/s10853-007-2070-3 ↗
20. Glasses in bone regeneration: A multiscale issue10.1016/j.jnoncrysol.2015.03.025 ↗
21. Facile synthetic route to hollow gadolinium oxide spheres with tunable thickness10.1049/mnl.2012.0718 ↗
22. Biocompatibility of magnetic resonance imaging nanoprobes improved by transformable gadolinium oxide nanocoils10.1021/jacs.8b08118 ↗
23. Synthesis of porous gadolinium oxide nanosheets for cancer therapy and magnetic resonance imaging10.1016/j.matlet.2020.127375 ↗
24. Europium-doped gadolinium oxide nanoparticles: A potential photoluminescencent probe for highly selective and sensitive detection of Fe3+ and Cr3+ ions10.1016/j.snb.2016.12.002 ↗
25. Y2O3 Nanoparticles Caused Bone Tissue Damage by Breaking the Intracellular Phosphate Balance in Bone Marrow Stromal Cells10.1021/acsnano.8b06211 ↗
26. Comparative study of toxicological assessment of yttrium oxide nano-and microparticles in Wistar rats after 28 days of repeated oral administration10.1093/mutage/gey044 ↗
27. Cytotoxicity and genotoxicity caused by yttrium oxide nanoparticles in HEK293 cells10.2147/IJN.S52625 ↗
28. Toxicity of Ce2O3/TiO2 composite nanofibers against S. aureus and S. typhimurium: A novel electrospun material for disinfection of food pathogens10.1016/j.colsurfa.2012.08.058 ↗
29. Facile synthesis and potential application of Ni0.6Zn0.4Fe2O4 and Ni0.6Zn0.2Ce0.2Fe2O4 magnetic nanocubes as a new strategy in sewage treatment10.1016/j.jenvman.2020.110816 ↗
30. Green Synthesis of Cerium Oxide Nanoparticles (CeO2 NPs) and Their Antimicrobial Applications: A Review10.2147/IJN.S255784 ↗
31. Synthesis and in vitro characterization of cerium oxide mixed calcium oxy fluoro borophosphate bioactive glasses by means of spectroscopic studies10.1016/j.jnoncrysol.2018.02.035 ↗
32. Green synthesis of Ce3+ rich CeO2 nanoparticles and its antimicrobial studies10.1016/j.matlet.2017.11.097 ↗
33. Comparison Study on the Antibacterial Activity of Nano- or Bulk-Cerium Oxide10.1166/jnn.2011.3858 ↗
34. Antibacterial Activity of Polymer Coated Cerium Oxide Nanoparticles10.1371/journal.pone.0047827 ↗
35. Mesoporous bioactive scaffolds prepared with cerium-, gallium- and zinc-containing glasses10.1016/j.actbio.2012.09.024 ↗
36. Yttrium oxide nanoparticle loaded scaffolds with enhanced cell adhesion and vascularization for tissue engineering applications10.1016/j.msec.2019.109801 ↗
37. Synthesis and characterization of cerium- and gallium-containing borate bioactive glass scaffolds for bone tissue engineering10.1007/s10856-014-5368-0 ↗
38. Surface-engineered multifunctional Eu: Gd2O3 nanoplates for targeted and pH-responsive drug delivery and imaging applications10.1021/acsami.6b12804 ↗
39. Controlled Synthesis of Ultrathin Lanthanide Oxide Nanosheets and Their Promising pH-Controlled Anticancer Drug Delivery10.1002/chem.201406470 ↗
40. PEG coated and doxorubicin loaded multimodal Gadolinium oxide nanoparticles for simultaneous drug delivery and imaging applications10.1016/j.ijpharm.2017.05.027 ↗
41. Up-Conversion Y2O3: Yb3+, Er3+ Hollow Spherical Drug Carrier with Improved Degradability for Cancer Treatment10.1021/acsami.6b07215 ↗
42. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer10.2147/IJN.S139246 ↗
43. Surface and interfacial engineering of iron oxide nanoplates for highly efficient magnetic resonance angiography10.1021/nn507193f ↗
44. Er3+ -Doped Y2O3 Nanophosphors for Near-Infrared Fluorescence Bioimaging Applications10.1111/jace.12476 ↗
45. Development of Liposome-Encapsulated, Rare-Earth-Doped Y2O3 Nanoparticles as Fluorescent Probes10.1002/ejic.201000201 ↗
46. Long-circulating Gd2O3: Yb3+, Er3+ up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging10.1016/j.biomaterials.2012.11.009 ↗
47. Novel synthesis of silica-coated Eu: Gd2O3 nanoparticles by polyol route at low temperature for bimodal cancer imaging10.1088/2053-1591/ab06e4 ↗
48. Terbium-doped gadolinium oxide nanoparticles prepared by laser ablation in liquid for use as a fluorescence and magnetic resonance imaging dual-modal contrast agent10.1039/C4CP04380D ↗
49. Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application10.1088/0957-4484/26/36/365102 ↗
50. Single-Phase Dy 2 O 3 :Tb 3+ Nanocrystals as Dual-Modal Contrast Agent for High Field Magnetic Resonance and Optical Imaging10.1021/cm2003066 ↗
51. Synthesis, characterization, and X-ray attenuation properties of polyacrylic acid-coated ultrasmall heavy metal oxide (Bi2O3, Yb2O3, NaTaO3, Dy2O3, and Gd2O3) nanoparticles as potential CT contrast agents10.1016/j.colsurfa.2019.05.033 ↗
52. Effect of Eu doping concentration on fluorescence and magnetic resonance imaging properties of Gd2O3: Eu3+ nanoparticles used as dual-modal contrast agent10.1088/1361-6528/aad347 ↗
53. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent10.1016/j.nano.2017.12.005 ↗
54. Gd2O3 nanoparticles stabilized by hydrothermally modified dextrose for positive contrast magnetic resonance imaging10.1016/j.jmmm.2015.11.075 ↗
55. Pulsed Laser Ablation for Obtaining Contrast Agents Based on Dysprosium Oxide (Dy2O3) Nanoparticles10.1007/s11018-017-1176-5 ↗
56. Magnetic and fluorescent Gd2O3: Yb3+/Ln3+ nanoparticles for simultaneous upconversion luminescence/MR dual modal imaging and NIR-induced photodynamic therapy10.2147/IJN.S118938 ↗
57. X. Shi, Z. Zhang, Z. Hu, J. Tian, Europium-doped Gadolinium Oxide Nanoparticles Mediated Radiopharmaceutical Excited Fluorescence Imaging, in: 2019 IEEE Nucl. Sci. Symp. Med. Imaging Conf., IEEE, n.d.: pp. 1–2.10.1109/NSS/MIC42101.2019.9059705 ↗
58. A Novel Paramagnetic Nanoparticle T2 Magnetic Resonance Imaging Contrast Agent With High Colloidal Stability: Polyacrylic Acid-Coated Ultrafine Dysprosium Oxide Nanoparticles10.1002/bkcs.12074 ↗
59. Cyclic RGD-Coated Ultrasmall Gd2O3 Nanoparticles as Tumor-Targeting Positive Magnetic Resonance Imaging Contrast Agents10.1002/ejic.201800023 ↗
60. Poly (lactic-co-glycolic acid) encapsulated gadolinium oxide nanoparticles for MRI-based cell tracking10.1166/jnn.2013.7435 ↗
61. Fluorescein-polyethyleneimine coated gadolinium oxide nanoparticles as T 1 magnetic resonance imaging (MRI)–cell labeling (CL) dual agents10.1039/c2ra21052e ↗
62. Ultrasonication Mediated Fabrication of Glycine Coated Gadolinium Oxide Nanoparticles as MRI Contrast Agents
63. Facile Synthesis of Single-Phase Mesoporous Gd2O3 :Eu Nanorods and Their Application for Drug Delivery and Multimodal Imaging10.1002/ppsc.201300342 ↗
64. Glutathione-mediated clearable nanoparticles based on ultrasmall Gd2O3 for MSOT/CT/MR imaging guided photothermal/radio combination cancer therapy10.1021/acs.molpharmaceut.9b00332 ↗
65. Designing Tripodal and Triangular Gadolinium Oxide Nanoplates and Self-Assembled Nanofibrils as Potential Multimodal Bioimaging Probes10.1021/nn4004583 ↗
66. Impact of agglomeration on the relaxometric properties of paramagnetic ultra-small gadolinium oxide nanoparticles10.1088/0957-4484/22/29/295103 ↗
67. FITC-Dextran entrapped and silica coated gadolinium oxide nanoparticles for synchronous optical and magnetic resonance imaging applications10.1016/j.ijpharm.2016.03.040 ↗
68. E. Hemmer, Y. Kohl, S. Mathur, H. Thielecke, K. Soga, Solvothermal Synthesis of Gadolinium Hydroxide and Oxide Powders and Their Potential for Biomedical Applications, in: 2010: pp. 27–37. https://doi.org/10.1002/9780470909812.ch3.10.1002/9780470909812.ch3 ↗
69. In situ functionalization of gadolinium oxide nanoparticles with polyethylene glycol (PEG) by pulsed laser ablation in a liquid medium (PLAL)10.1016/j.jsamd.2018.08.003 ↗
70. Carbon-coated ultrasmall gadolinium oxide (Gd2O3@C) nanoparticles: Application to magnetic resonance imaging and fluorescence properties10.1016/j.colsurfa.2019.124261 ↗
71. Boron nitride nanotubes radiolabeled with 153Sm and 159Gd: Potential application in nanomedicine10.1016/j.apradiso.2019.109032 ↗
72. Multicolor nanoprobes based on silica-coated gadolinium oxide nanoparticles with highly reduced toxicity10.1039/C5RA27685C ↗
73. Cyclic RGD-Coated Ultrasmall Gd2O3 Nanoparticles as Tumor-Targeting Positive Magnetic Resonance Imaging Contrast Agents10.1002/ejic.201800023 ↗
74. Functionalized multimodal ZnO@Gd2O3 nanosystems to use as perspective contrast agent for MRI10.1016/j.apsusc.2017.01.274 ↗
75. Surface-engineered gadolinium oxide nanorods and nanocuboids for bioimaging
76. Encapsulation of Gadolinium Oxide Nanoparticle (Gd2O3) Contrasting Agents in PAMAM Dendrimer Templates for Enhanced Magnetic Resonance Imaging in Vivo10.1021/acsami.6b14075 ↗
77. In Vivo Positive Magnetic Resonance Imaging Applications of Poly(methyl vinyl ether-alt-maleic acid)-coated Ultra-small Paramagnetic Gadolinium Oxide Nanoparticles10.3390/molecules25051159 ↗
78. Tumor-specific design of PEGylated gadolinium-based nanoscale particles: Facile synthesis, characterization, and improved magnetic resonance imaging of metastasis lung cancer10.1016/j.jphotobiol.2019.111669 ↗
79. NMR relaxometric properties and cytotoxicity of Gd2O3 nanoparticle suspensions in an organic liquid10.1007/s11051-014-2663-0 ↗
80. Cytotoxic aspects of gadolinium oxide nanostructures for up-conversion and NIR bioimaging10.1016/j.actbio.2012.08.045 ↗
81. Bulk Yttria as a Host for Lanthanides in Biomedical Applications: Influence of Concentration Gradients on Structural, Mechanical, Optical, and in Vitro Imaging Behavior10.1021/acsabm.9b00718 ↗
82. Resonant excited UV luminescence of the Gd3+ centres in borate glasses, co-doped with Gd and Ag10.1016/j.optmat.2018.03.050 ↗
83. TPAOH assisted size-tunable Gd2O3 @mSi core–shell nanostructures for multifunctional biomedical applications10.1039/C7CC07975C ↗
84. Synthesis, Characterization, and Enhanced Cancer-Imaging Application of Trans-activator of Transcription Peptide-conjugated Ultrasmall Gadolinium Oxide Nanoparticles10.1002/bkcs.11404 ↗
85. Y2O3 decorated TiO2 nanoparticles: Enhanced UV attenuation and suppressed photocatalytic activity with promise for cosmetic and sunscreen applications
86. Development of near infrared-fluorescent nanophosphors and applications for cancer diagnosis and therapy10.1155/2010/491471 ↗
87. Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment10.1002/adma.201902409 ↗
88. Synthesis, Characterization, and Enhanced Cancer-Imaging Application of Trans-activator of Transcription Peptide-conjugated Ultrasmall Gadolinium Oxide Nanoparticles10.1002/bkcs.11404 ↗
89. Y2O3 nanorods for cytotoxicity evaluation10.1016/j.ceramint.2020.05.172 ↗
90. Gadolinium oxide nanoparticles and aptamer-functionalized silver nanoclusters-based multimodal molecular imaging nanoprobe for optical/magnetic resonance cancer cell imaging10.1021/ac503026d ↗
91. Nanocrystalline cerium oxide films as a functional material for photodetectors of bioluminescent signal
92. Determination of apparent protein digestibility of live Artemia and a microparticulate diet in 8-week-old Atlantic cod Gadus morhua larvae10.1016/j.aquaculture.2008.11.033 ↗
93. Yttrium oxide (Y2O3) as an inert marker in digestibility studies with dogs, blue foxes and mink fed diets containing different protein sources10.1111/j.1439-0396.2006.00665.x ↗
94. Determination of 8-hydroxy-2′-deoxyguanosine oxidative stress biomarker using dysprosium oxide nanoparticles@reduced graphene oxide10.1039/C8QI00727F ↗
95. Application of luminescent Eu:Gd2O3 nanoparticles to the visualization of protein micropatterns10.1117/1.2136347 ↗
96. An Efficient Electrocatalyst for the Nano-Level Detection of Neurotransmitter (Dopamine) in Biologic Matrices based on Samarium (III) Oxide Nanoparticles; An Electrochemical Approaches10.20964/2020.07.95 ↗
97. Bacteriophages as factories for Eu2O3 nanoparticle synthesis10.1021/acs.bioconjchem.7b00119 ↗
98. Optical characterization of gold and Er3+: Y2O3 nanoparticles for biosensor applications
99. Two-dimensional ytterbium oxide nanodisks based biosensor for selective detection of urea10.1016/j.bios.2017.06.015 ↗
100. Erbium Oxide as pH-Sensing Membranes in Extended Gate Field Effect Transistors10.1166/asl.2012.3665 ↗